Funder: Patient-Centered Outcomes Research Institute (PCORI)
Due Dates: August 12, 2025 (Online Opens) | September 23, 2025 (LOI Deadline) | January 13, 2026 (Application Deadline)
Funding Amounts: Up to $12 million direct costs per project; maximum project period of 5 years.
Summary: Supports comparative clinical effectiveness research (CER) studies to address symptom management, diagnosis, and care delivery for individuals with rare diseases.
Key Information: Patient and stakeholder engagement is required; both single and cross-disease studies are eligible; randomized trials preferred but other rigorous CER designs considered.